Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01651299 · ClinicalTrials.gov registry record
Copperhead Envenomation Observational Study
A clinical trial, sponsored by BTG International.
- Completed
- Registry status
- 20
- Enrollment target
NCT01651299 is a clinical trial that has completed, run by BTG International. The registered enrollment target is 20 participants.
The verdict
NCT01651299 has completed, sponsored by BTG International.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate the responsiveness and utility of several clinical outcome assessments in the setting of copperhead snakebite. The secondary objective is to characterize the clinical course of signs, symptoms and impairment during the recovery phase of copperhead snakebite.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01651299
The ClinicalTrials.gov registry entry for NCT01651299 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTG International, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01651299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01651299 about?
NCT01651299 is a clinical study titled "Copperhead Envenomation Observational Study". The primary objective of the study is to evaluate the responsiveness and utility of several clinical outcome assessments in the setting of copperhead snakebite. The secondary objective is to characterize the clinical course of signs, symptoms and impairment during the recovery phase of copperhead sn...
What is the current status of trial NCT01651299?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-07. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01651299?
This trial is sponsored by BTG International, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.